Prilocaine (Citanest) 0.5% inj, 50 ml vial: Supply issue resolved

Aspen has advised us that stock of prilocaine (Citanest) 0.5% injections (Pharmacode 2089971) has returned to good levels.

Affected product

In March 2023, Aspen advised that supply of prilocaine (Citanest) 0.5% inj, 50 ml vial was delayed until July 2023 due to manufacturing issues.

HML Listing for prilocaine(external link)

Prilocaine 2% inj, 5ml ampoule is listed as ‘any brand’ which means we do not have a contract for supply and hospitals are able to purchase whatever brand is available.

This is a hospital-only medicine. It is not listed on the Community Schedule. 

Who to contact

If you have questions about this supply issue, email enquiry@pharmac.govt.nz